The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...

A street drug police say is starting to resurface ... The FDA approved the antidepressant this week and it's a nasal spray. Speaker 10: Spravato is the first new type of depression treatment ...

The United States Food and Drug Administration (FDA) has approved Spravato (esketamine), a nasal spray from Johnson & Johnson, as a stand-alone therapy for adults with major depressive disorder ...

To learn whether Spravato interacts with supplements, herbs, or vitamins, see the “Spravato and other interactions” section. If you have questions about drug interactions that may affect you ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper ...

Called Spravato, a brand name for esketamine, and developed by Johnson & Johnson, the drug is a nasal spray designed to treat severe forms of depression that don't respond to other medications.

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of sufficient efficacy, the drug and medical device maker said on Thursday.

This is because the Food and Drug Administration (FDA ... S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major ...

Spravato is approved as an adjunctive therapy administered by a nasal spray and is based on esketamine, a form of the drug ketamine, an anaesthetic commonly used illegally for recreational purposes.

Stella Mental Health in Westmont specializes in medication management, Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion ...